Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05256290 |
|---|---|
| Brief Title: | Phase 1/2 Study of BDTX-1535 in Patients With Glioblastoma or Non-Small Cell Lung Cancer With EGFR Mutations |
| First Submitted : | February 15, 2022 |
| First Submitted that Met QC Criteria : | February 24, 2022 |
| First Posted : | February 25, 2022 |
| Last Update Submitted that Met QC Criteria : | March 5, 2024 |
| Last Update Posted : | March 6, 2024 |